Four years after Sanofi shelled out $125 million for global rights to Biond Biologic | The company is handing back the tumor ...

We recently published a list of 10 Best Immunology Stocks To Buy Now. In this article, we are going to take a look at where ...

In this article, we are going to take a look at where Sanofi (NASDAQ:SNY) stands against the other pharmaceutical stocks.

Sanofi and CD&R have signed a share purchase agreement for the sale of a 50% stake in the consumer health business.

Sanofi's deep partnership with OpenAI could be a huge differentiating factor. Check out why I rate SNY stock a buy.

Detailed results presented at a medical congress help reinforce analyst expectations the drug, called duvakitug, will be ...

Biopharma doubles down on immunology and inflammation as companies target new pathways and seek to improve on current options ...

Kuehne+Nagel supports Sanofi in multiple countries worldwide, including Hungary, the UK, and the UAE, by providing customised ...

With a market valuation of Rs 11,574.76 Cr, Sanofi Indias shares ended Fridays trading session on the BSE 0.58% higher at Rs ...

In this article, we are going to take a look at where Sanofi (NASDAQ ... and medical technology. Pharmaceutical companies in particular have received much attention as the demand for speedy ...